An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to Italian ...
If we want our vaccine production process to be more robust and faster, we’ll have to stop relying on chicken eggs. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech ...
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services ...
A University of Waterloo professor is part of an international coalition revolutionizing vaccine production with new health care technology. The tech aims to support local vaccine production, cutting ...
Grant marks Alveo's entry into vaccine manufacturing market, extending its molecular detection platform beyond infectious disease diagnostics. ALAMEDA, Calif., May 26, 2026 /PRNew ...
So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and treatments against a long ...
Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...
Researchers are pitching a new vaccine method for infants that offers continued protection with just a single dose, even if the virus mutates, according to a new study that could set the stage for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results